1. Home
  2. MERC vs BTMD Comparison

MERC vs BTMD Comparison

Compare MERC & BTMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mercer International Inc.

MERC

Mercer International Inc.

HOLD

Current Price

$0.64

Market Cap

60.2M

ML Signal

HOLD

Logo Biote Corp.

BTMD

Biote Corp.

HOLD

Current Price

$2.37

Market Cap

65.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MERC
BTMD
Founded
1968
2012
Country
Canada
United States
Employees
N/A
N/A
Industry
Paper
Medicinal Chemicals and Botanical Products
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
60.2M
65.8M
IPO Year
2005
2021

Fundamental Metrics

Financial Performance
Metric
MERC
BTMD
Price
$0.64
$2.37
Analyst Decision
Hold
Strong Buy
Analyst Count
3
3
Target Price
$2.25
$2.83
AVG Volume (30 Days)
785.0K
410.5K
Earning Date
05-07-2026
05-06-2026
Dividend Yield
7.01%
N/A
EPS Growth
N/A
722.22
EPS
N/A
0.06
Revenue
$1,169,145,000.00
$192,219,000.00
Revenue This Year
$13.75
$2.03
Revenue Next Year
$10.12
$6.58
P/E Ratio
N/A
$36.33
Revenue Growth
25.50
N/A
52 Week Low
$0.53
$1.27
52 Week High
$4.47
$4.75

Technical Indicators

Market Signals
Indicator
MERC
BTMD
Relative Strength Index (RSI) 43.40 58.73
Support Level N/A $2.37
Resistance Level $0.81 $2.44
Average True Range (ATR) 0.07 0.17
MACD -0.00 0.02
Stochastic Oscillator 43.61 96.75

Price Performance

Historical Comparison
MERC
BTMD

About MERC Mercer International Inc.

Mercer International Inc is a forest products company with two reportable operating segments in pulp and solid wood. The pulp segment consists of the manufacture, sale, and distribution of pulp, electricity, and chemicals. The company has a geographical presence in the USA, Germany, China, and Other countries, where the maximum of revenue is generated from the China. The majority of the revenue is generated from the Pulp segment.

About BTMD Biote Corp.

Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The company provides support to medical practitioners through training, practice development, and operational services to establish and manage hormone therapy centers. Its activities include educating practitioners on identifying and treating hormone-related conditions. The company generates revenues by charging the Biote-partnered clinics fees associated with the Biote Method and from the sale of Biote-branded dietary supplements.

Share on Social Networks: